Cardiothoracic & vascular anesthesia

Pan-Immune-Inflammation Value: A Novel Biomarker for Predicting Postoperative Atrial Fibrillation in Young Patients Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG)

J Cardiothorac Vasc AnesthPublished Retrospective observational cohort study

Main finding · PIV as predictor of postoperative new-onset AFResult — go to the resultOdds ratio 1.001 95% CI 1.000–1.002

Authors' conclusion

Our study demonstrated for the first time in the literature that the PIV and the NLR significantly and independently predicted new-onset AF following off-pump CABG.

Study context

Population
Young patients (age ≤50 years) undergoing off-pump CABG, tertiary referral hospital in Turkey
Participants
223 patients
Exposure
Atrial fibrillation (AF) vs non-AF after off-pump CABG
  • AFn = 31
  • non-AFn = 192reference
Outcome
PIV measurement
Methodological detailssingle-centre
  • Single-centre

Main finding

PIV as predictor of postoperative new-onset AF

Odds ratio

1.001

95% CI 1.000–1.002

AF vs non-AF after off-pump CABG
OR 1.001 (95% CI 1.000–1.002)

As reported in the abstract

PIV cut-off for predicting postoperative AF
307.9
Sensitivity
93.5%
Specificity
71.4%

Observational data: associations, not effects.

Further findings

Blood counts and inflammatory indices

Platelet, neutrophil, lymphocyte, monocyte counts, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index and PIV significantly different between groups

Preoperative clinical features, operative and postoperative data

No significant differences between groups except hospital LOS

Original publication

Pan-Immune-Inflammation Value: A Novel Biomarker for Predicting Postoperative Atrial Fibrillation in Young Patients Undergoing Off-Pump CABG. J Cardiothorac Vasc Anesth. Published 5 March 2025. doi:10.1053/j.jvca.2025.02.050

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.